Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Axogen, Inc. (AXGN)

$38.06 +3.76% NASDAQ: AXGN · 15-min delayed
  • ALACHUA, Florida
  • Public · NASDAQ: AXGN
  • 622 employees
$2.1BMarket cap
$225.2MRevenue · FY2025
-$15.7MNet income
622Employees
AXGNNASDAQ
1986IPO

About Axogen, Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$225.2M
Net income
-$15.7M
Total assets
$221.7M
Market cap
$2.1B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: AXGN
$38.06 +3.76%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$15.59 $51.73

52-week range

Market cap
$2.1B
Shares outstanding
55.2M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Dec 17, 1986

Axogen, Inc. (AXGN) Stock Price

  • Reported a net loss of $15.7M in FY2025.
  • Trading 26% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Axogen, Inc..

Write a review
Newsroom

News about Axogen, Inc.

News & sentiment via Polygon.io

FAQ

Axogen, Inc.: frequently asked questions

Is Axogen, Inc. an American company?

Axogen, Inc. is a US-based company headquartered in Alachua, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Axogen, Inc. headquartered?

Axogen, Inc. is headquartered in Alachua, Florida, United States.

Is Axogen, Inc. publicly traded?

Yes — Axogen, Inc. is a publicly traded company. Its stock trades under the ticker symbol AXGN on the NASDAQ.

What does Axogen, Inc. do?

Axogen, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →